|
Yale SPORE in Skin Cancer
|
3P50CA121974-05S1
|
$500,000
|
$300,000
|
HALABAN, RUTH
|
YALE UNIVERSITY
|
|
YALE COMPREHENSIVE CANCER CENTER
|
3P30CA016359-33S1
|
$35,000
|
$5,600
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
YALE COMPREHENSIVE CANCER CENTER
|
3P30CA016359-33S2
|
$5,000
|
$800
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
YALE COMPREHENSIVE CANCER CENTER
|
5P30CA016359-33
|
$1,795,225
|
$287,236
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
Wound Response Genes in Cancer Progression
|
5R01CA118750-05
|
$289,676
|
$289,676
|
CHANG, HOWARD
|
STANFORD UNIVERSITY
|
|
Wnt-Dependent Neurite Outgrowth in Ewing Tumor Cells
|
ZIA BC 011224
|
$258,001
|
$77,400
|
Rubin, Jeffrey
|
CCR (NCI)
|
|
Wnt Signaling and Prostate Cancer Bone Metastasis
|
1F32CA165689-01
|
$51,326
|
$51,326
|
Simmons, Jessica
|
OHIO STATE UNIVERSITY
|
|
Wnt antagonist genes in kidney tumor progression and metastasis
|
5R01CA130860-04
|
$603,974
|
$603,974
|
DAHIYA, RAJVIR
|
NORTHERN CALIFORNIA INSTITUTE RES & EDUC
|
|
Wnt 7a and Its Role in EMT and Lung Cancer Metastasis
|
5R21CA153268-02
|
$79,044
|
$79,044
|
WINN, ROBERT
|
UNIVERSITY OF COLORADO DENVER
|
|
Wine for Cancer-Associated Anorexia
|
5R01CA124614-05
|
$203,881
|
$203,881
|
JATOI, AMINAH
|
MAYO CLINIC
|
|
Whole-Body PET/CT Assessment of Tumor Perfusion Using Generator-Produced 62Cu
|
4R01CA140299-03
|
$420,747
|
$210,374
|
Fletcher, James
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Vitamin D status, Gene Polymorphism and Breast Cancer Progression/Prognosis
|
1R03CA156648-01
|
$290
|
$145
|
Dorjgochoo, Tsogzolmaa
|
VANDERBILT UNIVERSITY
|
|
Vitamin D in Prostate Cancer: Tumor Vasculature Effects
|
5R01CA095045-09
|
$272,579
|
$272,579
|
JOHNSON, CANDACE
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Vitamin D Analogs for Chemoprevention of Prostate CAncer
|
4R01CA095367-07
|
$374,697
|
$93,674
|
FOSTER, BARBARA
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Virus-host interactions in hepatocarcinogenesis
|
5P01CA123328-05
|
$1,042,962
|
$521,481
|
OU, J.-H. James
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
VHL tumor suppressor gene and the initiation of renal cell carcinoma
|
2R01CA109860-07
|
$328,499
|
$328,499
|
HSU, TIEN
|
BOSTON MEDICAL CENTER
|
|
VEGFs in tumor lymphatic metastasis
|
4R01CA142262-03
|
$453,456
|
$453,456
|
DVORAK, HAROLD
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
VEGF Gene Amplification/Haplotype as Biomarkers for Bevacizumab in Breast Cancer
|
1R01CA155311-01A1
|
$336,052
|
$336,052
|
Schneider, Bryan
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
VEGF and PDGF in angiogenesis and tumor progression
|
5R37CA050286-23
|
$460,615
|
$460,615
|
CHERESH, DAVID
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Vav3 Oncogene in Prostate Cancer
|
5R01CA119935-05
|
$258,757
|
$258,757
|
LU, SHAN
|
UNIVERSITY OF CINCINNATI
|
|
Vasculogenesis in Ewing's Sarcoma: Implications for Therapy
|
5R01CA103986-07
|
$246,403
|
$246,403
|
Kleinerman, Eugenie
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Vascular Biology in Cancer
|
ZIA BC 011390
|
$854,488
|
$256,346
|
Lin, Pengnian Charles
|
CCR (NCI)
|
|
Vanderbilt In Vivo Cellular and Molecular Imaging Center
|
5P50CA128323-04
|
$1,200,072
|
$120,007
|
GORE, JOHN
|
VANDERBILT UNIVERSITY
|
|
Validation of Genomic Targets in Melanoma
|
2R01CA114337-07A1
|
$370,543
|
$370,543
|
KASHANI-SABET, MOHAMMED
|
CALIFORNIA PACIFIC MED CTR RES INSTITUTE
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-38S1
|
$74,970
|
$9,746
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-38S2
|
$139,926
|
$18,190
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-38
|
$4,555,705
|
$592,242
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Utility-Assessment for Co-Morbidities in Prostate Cancer
|
5R21CA137279-02
|
$168,861
|
$42,215
|
DALE, WILLIAM
|
UNIVERSITY OF CHICAGO
|
|
UT M.D. Anderson Cancer Center
|
5U10CA045809-23
|
$2,179,856
|
$326,978
|
FISCH, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Uses of GEM models for Translational Cancer Research
|
5U01CA141508-03
|
$817,169
|
$817,169
|
CHIN, LYNDA
|
DANA-FARBER CANCER INSTITUTE
|
|
Use of Mouse Models of Human Rhabdomyosarcoma to Study Progression to Metastasis
|
ZIA BC 010871
|
$57,184
|
$40,028
|
Merlino, Glenn
|
CCR (NCI)
|
|
Use of aAPC for Melanoma Adoptive Immunotherapy
|
2R01CA108835-06A2
|
$318,780
|
$318,780
|
SCHNECK, JONATHAN
|
JOHNS HOPKINS UNIVERSITY
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
2P30CA014089-36
|
$6,160,984
|
$985,757
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-36S1
|
$50,000
|
$8,000
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-36S2
|
$244,500
|
$39,120
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-36S3
|
$74,923
|
$11,988
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Urokinase Receptor-initiated Cell-signaling
|
5R01CA094900-11
|
$259,520
|
$259,520
|
GONIAS, STEVEN
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Urokinase Receptor Integrin Interactions in Lung Cancer
|
5R01CA125564-05
|
$284,744
|
$284,744
|
CHAPMAN, HAROLD
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
UPRCCC/MDACC: Partnership for Excellence in Cancer Research
|
3U54CA096297-09S1
|
$201,528
|
$68,520
|
Frontera, Walter
|
UNIVERSITY OF PUERTO RICO MED SCIENCES
|
|
UPRCCC/MDACC: Partnership for Excellence in Cancer Research
|
5U54CA096297-09
|
$1,494,018
|
$507,966
|
Frontera, Walter
|
UNIVERSITY OF PUERTO RICO MED SCIENCES
|
|
UPRCCC/MDACC: Partnership for Excellence in Cancer Research
|
5U54CA096300-09
|
$1,210,404
|
$411,537
|
DUBOIS, RAYMOND
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
UNMC Eppley Cancer Center Support Grant
|
2P30CA036727-25
|
$1,504,111
|
$496,357
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-25S1
|
$74,642
|
$24,632
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-07S1
|
$49,474
|
$2,968
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-07S2
|
$75,000
|
$4,500
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-07S3
|
$140,000
|
$8,400
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
University of New Mexico Cancer Center Support
|
5P30CA118100-07
|
$1,934,104
|
$116,046
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-23S2
|
$50,000
|
$6,000
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-23S3
|
$5,694,947
|
$683,394
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
2P30CA134274-04
|
$1,565,163
|
$266,078
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
Total relevant funding to Metastasis for this search: $404,767,176
|